Etiopathogenesis of Fibromyalgia

키워드

참고문헌 (206)

1. White KP, "The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario", J Rheumatol, 26, pp.1570~1576 (1999)
2. Spaeth M, "Epidemiology, costs, and the economic burden of fibromyalgia", Arthritis Res Ther, 11, pp.117~ (2009)
3. Häuser W, "Fibromyalgia syndrome: under-, over- and misdiagnosis", Clin Exp Rheumatol, 37(Suppl 116), pp.90~97 (2019)
4. Bellato E, "Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment", Pain Res Treat, 2012, pp.426130~ (2012)
5. Schmidt-Wilcke T, "Fibromyalgia: from pathophysiology to therapy", Nat Rev Rheumatol, 7, pp.518~527 (2011)
6. Sarzi-Puttini P, "Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment", Nat Rev Rheumatol, 16, pp.645~660 (2020)
7. Siracusa R, "Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update", Int J Mol Sci, 22, pp.3891~ (2021)
8. Wolfe F, "et al : 2016 Revisions to the 2010", 2011 fibromyalgia diagnostic criteria, 2016, pp.46, 319~329
9. Arnold LM, "Family study of fibromyalgia", Arthritis Rheum, 50, pp.944~952 (2004)
10. Arnold LM, "The fibromyalgia family study : a genome-wide linkage scan study", Arthritis Rheum, 65, pp.1122~1128 (2013)
11. Jones KD, "Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia", Clin Exp Rheumatol, 34(2 Suppl 96), pp.S89~S98 (2016)
12. Rahman MS, "Genome-wide association study identifies RNF123 locus as associated with chronic widespread musculoskeletal pain", Ann Rheum Dis, 80, pp.1227~1235 (2021)
13. Mogil JS, "Pain genetics: past, present and future", Trends Genet, 28, pp.258~266 (2012)
14. Smith SB, "Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia", Arthritis Rheum, 64, pp.584~593 (2012)
15. Buskila D, "Biology and therapy of fibromyalgia : genetic aspects of fibromyalgia syndrome", Arthritis Res Ther, 8, pp.218~ (2006)
16. Limer KL, "Exploring the genetic susceptibility of chronic widespread pain : the tender points in genetic association studies", Rheumatology(Oxford), 47, pp.572~577 (2008)
17. Graeff FG, "Serotonergic systems", Psychiatr Clin North Am, 20, pp.723~739 (1997)
18. Roth BL, "Multiple serotonin receptors : clinical and experimental aspects", Ann Clin Psychiatry, 6, pp.67~78 (1994)
19. Roth BL, "Molecular and cellular mechanisms for the polarized sorting of serotonin receptors : relevance for genesis and treatment of psychosis", Crit Rev Neurobiol, 16, pp.229~236 (2004)
20. Mergener M, "Influence of the interaction between environmental quality and T102C SNP in the HTR2A gene on fibromyalgia susceptibility", Rev Bras Reumatol, 51, pp.594~602 (2011)
21. Lee YH, "Candidate gene studies of fibromyalgia: a systematic review and meta-analysis", Rheumatol Int, 32, pp.417~426 (2012)
22. Offenbaecher M, "Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region", Arthritis Rheum, 42, pp.2482~2488 (1999)
23. Oswald LM, "Catechol-O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone : a preliminary report", Biol Psychiatry, 55, pp.102~105 (2004)
24. Drabant EM, "Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation", Arch Gen Psychiatry, 63, pp.1396~1406 (2006)
25. Gürsoy S, "Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome", Rheumatol Int, 23, pp.104~107 (2003)
26. Diatchenko L, "Genetic basis for individual variations in pain perception and the development of a chronic pain condition", Hum Mol Genet, 14, pp.135~143 (2005)
27. Martínez-Jauand M, "Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase(COMT)gene", Eur J Pain, 17, pp.16~27 (2013)
28. Inanir A, "Clinical symptoms in fibromyalgia are associated to catechol-O-methyltransferase(COMT)gene Val158Met polymorphism", Xenobiotica, 44, pp.952~956 (2014)
29. Lee C, "Association of catechol-O-methyltransferase single nucleotide polymorphisms, ethnicity, and sex in a large cohort of fibromyalgia patients", BMC Rheumatol, 2, pp.38~ (2018)
30. Jarcho JM, "Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction", Pain, 153, pp.744~754 (2012)
31. Wood PB, "Role of central dopamine in pain and analgesia", Expert Rev Neurother, 8, pp.781~797 (2008)
32. Wood PB, "Fibromyalgia patients show an abnormal dopamine response to pain", Eur J Neurosci, 25, pp.3576~3582 (2007)
33. Buskila D, "An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits", Mol Psychiatry, 9, pp.730~731 (2004)
34. Potvin S, "DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls", J Pain, 10, pp.969~975 (2009)
35. Solak Ö, "Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia", Rheumatol Int, 34, pp.1257~1261 (2014)
36. Ellerbrock I, "Polymorphisms of the μ-opioid receptor gene influence cerebral pain processing in fibromyalgia", Eur J Pain, 25, pp.398~414 (2021)
37. Kosek E, "The translocator protein gene is associated with symptom severity and cerebral pain processing in fibromyalgia", Brain Behav Immun, 58, pp.218~227 (2016)
38. Park DJ, "Polymorphisms of the TRPV2 and TRPV3 genes associated with fibromyalgia in a Korean population", Rheumatology(Oxford), 55, pp.1518~1527 (2016)
39. Park DJ, "Association between brain-derived neurotrophic factor gene polymorphisms and fibromyalgia in a Korean population : a multicenter study", Arthritis Res Ther, 20, pp.220~ (2018)
40. Wang F, "Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury : etiological contribution to complex regional pain syndromes(Part II)", Med Sci Monit, 20, pp.1188~1200 (2014)
41. Rahn EJ, "Cellular, molecular, and epigenetic mechanisms in non-associative conditioning: implications for pain and memory", Neurobiol Learn Mem, 105, pp.133~150 (2013)
42. Seo S, "Epigenetics: a promising paradigm for better understanding and managing pain", J Pain, 14, pp.549~557 (2013)
43. Menzies V, "Epigenetic alterations and an increased frequency of micronuclei in women with fibromyalgia", Nurs Res Pract, 2013, pp.795784~ (2013)
44. Ciampi de Andrade D, "Epigenetics insights into chronic pain : DNA hypomethylation in fibromyalgia : a controlled pilot-study", Pain, 158, pp.1473~1480 (2017)
45. Polli A, "DNA methylation and brain-derived neurotrophic factor expression account for symptoms and widespread hyperalgesia in patients with chronic fatigue syndrome and comorbid fibromyalgia", Arthritis Rheumatol, 72, pp.1936~1944 (2020)
46. Lewis BP, "Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets", Cell, 120, pp.15~20 (2005)
47. Baek D, "The impact of microRNAs on protein output", Nature, 455, pp.64~71 (2008)
48. Bjersing JL, "Profile of cerebrospinal microRNAs in fibromyalgia", PLoS One, 8, pp.e78762~ (2013)
49. Bjersing JL, "Profile of circulating microRNAs in fibromyalgia and their relation to symptom severity: an exploratory study", Rheumatol Int, 35, pp.635~642 (2015)
50. D’Agnelli S, "Fibromyalgia : genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers", Mol Pain, 15, pp.1744806918819944~ (2019)
51. Bradley LA, "Pathophysiology of fibromyalgia", Am J Med, 122(12 Suppl), pp.S22~S30 (2009)
52. Al-Allaf AW, "A case-control study examining the role of physical trauma in the onset of fibromyalgia syndrome", Rheumatology(Oxford), 41, pp.450~453 (2002)
53. Cruz BA, "Higher prevalence of fibromyalgia in patients infected with human T cell lymphotropic virus type I", J Rheumatol, 33, pp.2300~2303 (2006)
54. Demitrack MA, "Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome", Ann N Y Acad Sci, 840, pp.684~697 (1998)
55. Bennett RM, "An internet survey of 2,596 people with fibromyalgia", BMC Musculoskelet Disord, 8, pp.27~ (2007)
56. Suarez-Roca H, "Role of mu-opioid and NMDA receptors in the development and maintenance of repeated swim stress-induced thermal hyperalgesia", Behav Brain Res, 167, pp.205~211 (2006)
57. Nasu T, "Persistent deep mechanical hyperalgesia induced by repeated cold stress in rats", Eur J Pain, 14, pp.236~244 (2010)
58. Khasar SG, "Sound stress-induced long-term enhancement of mechanical hyperalgesia in rats is maintained by sympathoadrenal catecholamines", J Pain, 10, pp.1073~1077 (2009)
59. Nishiyori M, "Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants", Mol Pain, 7, pp.69~ (2011)
60. Suarez-Roca H, "Reduced GABA neurotransmission underlies hyperalgesia induced by repeated forced swimming stress", Behav Brain Res, 189, pp.159~169 (2008)
61. Quintero JE, "Amperometric measurement of glutamate release modulation by gabapentin and pregabalin in rat neocortical slices: role of voltage-sensitive Ca2+ α2δ-1 subunit", J Pharmacol Exp Ther, 338, pp.240~245 (2011)
62. Sluka KA, "Exercise-induced pain requires NMDA receptor activation in the medullary raphe nuclei", Med Sci Sports Exerc, 44, pp.420~427 (2012)
63. Buskila D, "Etiology of fibromyalgia: the possible role of infection and vaccination", Autoimmun Rev, 8, pp.41~43 (2008)
64. Hunskar GS, "Prevalence of fibromyalgia 10 years after infection with Giardia lamblia : a controlled prospective cohort study", Scand J Pain, 22, pp.348~355 (2021)
65. Fitzcharles MA, "Adjudication of fibromyalgia syndrome: challenges in the medicolegal arena", Pain Res Manag, 19, pp.287~292 (2014)
66. Harth M, "Fibromyalgia and disability adjudication: no simple solutions to a complex problem", Pain Res Manag, 19, pp.293~299 (2014)
67. Buskila D, "Developments in the scientific and clinical understanding of fibromyalgia", Arthritis Res Ther, 11, pp.242~ (2009)
68. Buskila D, "Increased rates of fibromyalgia following cervical spine injury: a controlled study of 161 cases of traumatic injury", Arthritis Rheum, 40, pp.446~452 (1997)
69. Clauw D, "The health consequences of the first Gulf war", BMJ, 327, pp.1357~1358 (2003)
70. Clauw DJ, "Unexplained symptoms after terrorism and war : an expert consensus statement", J Occup Environ Med, 45, pp.1040~1048 (2003)
71. McBeth J, "The association between tender points, psychological distress, and adverse childhood experiences: a community-based study", Arthritis Rheum, 42, pp.1397~1404 (1999)
72. Jones GT, "Adverse events in childhood and chronic widespread pain in adult life: results from the 1958 British Birth Cohort Study", Pain, 143, pp.92~96 (2009)
73. Haviland MG, "Traumatic experiences, major life stressors, and self-reporting a physician-given fibromyalgia diagnosis", Psychiatry Res, 177, pp.335~341 (2010)
74. Hellou R, "Self-reported childhood maltreatment and traumatic events among Israeli patients suffering from fibromyalgia and rheumatoid arthritis", Pain Res Manag, 2017, pp.3865249~ (2017)
75. Crofford LJ, "Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia", Arthritis Rheum, 37, pp.1583~1592 (1994)
76. Qiao ZG, "Electrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests", J Rheumatol, 18, pp.1383~1389 (1991)
77. Adler GK, "Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome", Am J Med, 106, pp.534~543 (1999)
78. Martínez-Lavín M, "Circadian studies of autonomic nervous balance in patients with fibromyalgia : a heart rate variability analysis", Arthritis Rheum, 41, pp.1966~1971 (1998)
79. Crofford LJ, "The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome", Z Rheumatol, 57(Suppl 2), pp.67~71 (1998)
80. Martinez-Lavin M, "Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia", Arthritis Res Ther, 9, pp.216~ (2007)
81. Tanriverdi F, "The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome", Stress, 10, pp.13~25 (2007)
82. Kuehl LK, "Increased basal mechanical pain sensitivity but decreased perceptual wind-up in a human model of relative hypocortisolism", Pain, 149, pp.539~546 (2010)
83. Michaux GP, "Experimental characterization of the effects of acute stresslike doses of hydrocortisone in human neurogenic hyperalgesia models", Pain, 153, pp.420~428 (2012)
84. van Middendorp H, "The effects of anger and sadness on clinical pain reports and experimentally-induced pain thresholds in women with and without fibromyalgia", Arthritis Care Res(Hoboken), 62, pp.1370~1376 (2010)
85. Griep EN, "Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome", J Rheumatol, 20, pp.469~474 (1993)
86. Pompili M, "The hypothalamic-pituitary-adrenal axis and serotonin abnormalities : a selective overview for the implications of suicide prevention", Eur Arch Psychiatry Clin Neurosci, 260, pp.583~600 (2010)
87. Dinan TG, "Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function", Life Sci, 58, pp.1683~1694 (1996)
88. McCain GA, "Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis", J Rheumatol Suppl, 19, pp.154~157 (1989)
89. Crofford LJ, "Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and", or chronic fatigue syndrome, 2004, pp.18, 314~325
90. McLean SA, "Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia", Neuropsychopharmacology, 31, pp.2776~2782 (2006)
91. Wingenfeld K, "HPA axis reactivity and lymphocyte glucocorticoid sensitivity in fibromyalgia syndrome and chronic pelvic pain", Psychosom Med, 70, pp.65~72 (2008)
92. Crofford LJ, "Neuroendocrine aspects of fibromyalgia", J Musculoskelet Pain, 2, pp.125~133 (1994)
93. Bennett RM, "Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia", J Rheumatol, 24, pp.1384~1389 (1997)
94. Lerma C, "Nocturnal heart rate variability parameters as potential fibromyalgia biomarker: correlation with symptoms severity", Arthritis Res Ther, 13, pp.R185~ (2011)
95. Kleinman L, "Assessment of sleep in patients with fibromyalgia : qualitative development of the fibromyalgia sleep diary", Health Qual Life Outcomes, 12, pp.111~ (2014)
96. Finan PH, "The association of sleep and pain: an update and a path forward", J Pain, 14, pp.1539~1552 (2013)
97. Mundal I, "Prevalence and long-term predictors of persistent chronic widespread pain in the general population in an 11-year prospective study: the HUNT study", BMC Musculoskelet Disord, 15, pp.213~ (2014)
98. Moldofsky H, "Musculosketal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects", Psychosom Med, 37, pp.341~351 (1975)
99. Moldofsky H, "Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation", Psychosom Med, 38, pp.35~44 (1976)
100. Mork PJ, "Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway", Arthritis Rheum, 64, pp.281~284 (2012)
101. Lentz MJ, "Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women", J Rheumatol, 26, pp.1586~1592 (1999)
102. Nicassio PM, "The contribution of pain, reported sleep quality, and depressive symptoms to fatigue in fibromyalgia", Pain, 100, pp.271~279 (2002)
103. Bigatti SM, "Sleep disturbances in fibromyalgia syndrome : relationship to pain and depression", Arthritis Rheum, 59, pp.961~967 (2008)
104. Hamilton NA, "Fibromyalgia : the role of sleep in affect and in negative event reactivity and recovery", Health Psychol, 27, pp.490~497 (2008)
105. Moldofsky H, "The significance of dysfunctions of the sleeping", waking brain to the pathogenesis and treatment of fibromyalgia syndrome, 2009, pp.35, 275~283
106. Irwin MR, "Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis", Sleep, 35, pp.537~543 (2012)
107. Smith MT, "The effects of sleep deprivation on pain inhibition and spontaneous pain in women", Sleep, 30, pp.494~505 (2007)
108. Onen SH, "The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects", J Sleep Res, 10, pp.35~42 (2001)
109. Roehrs T, "Sleep loss and REM sleep loss are hyperalgesic", Sleep, 29, pp.145~151 (2006)
110. Tononi G, "Sleep function and synaptic homeostasis", Sleep Med Rev, 10, pp.49~62 (2006)
111. Vyazovskiy VV, "Cortical firing and sleep homeostasis", Neuron, 63, pp.865~878 (2009)
112. Vijayan S, "Thalamic mechanisms underlying alpha-delta sleep with implications for fibromyalgia", J Neurophysiol, 114, pp.1923~1930 (2015)
113. Durkin JM, "How sleep shapes thalamocortical circuit function in the visual system", Annu Rev Vis Sci, 5, pp.295~315 (2019)
114. Flodin P, "Fibromyalgia is associated with decreased connectivity between pain- and sensorimotor brain areas", Brain Connect, 4, pp.587~594 (2014)
115. Caravan B, "Sleep spindles as a diagnostic and therapeutic target for chronic pain", Mol Pain, 16, pp.1744806920902350~ (2020)
116. Andersen ML, "Sleep disturbance induced by substance P in mice", Behav Brain Res, 167, pp.212~218 (2006)
117. Anderberg UM, "Elevated plasma levels of neuropeptide Y in female fibromyalgia patients", Eur J Pain, 3, pp.19~30 (1999)
118. Evengard B, "Chronic fatigue syndrome differs from fibromyalgia : no evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome", Pain, 78, pp.153~155 (1998)
119. Haack M, "Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers", Sleep, 30, pp.1145~1152 (2007)
120. Rizzi M, "Influence of autonomic nervous system dysfunction in the genesis of sleep disorders in fibromyalgia patients", Clin Exp Rheumatol, 35(Suppl 105), pp.74~80 (2017)
121. Boissevain MD, "Toward an integrated understanding of fibromyalgia syndrome. II. Psychological and phenomenological aspects", Pain, 45, pp.239~248 (1991)
122. Epstein SA, "Psychiatric disorders in patients with fibromyalgia : a multicenter investigation", Psychosomatics, 40, pp.57~63 (1999)
123. Yepez D, "Fibromyalgia and depression : a literature review of their shared aspects", Cureus, 14, pp.e24909~ (2022)
124. Giesecke T, "The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort", Arthritis Rheum, 52, pp.1577~1584 (2005)
125. Cohen H, "Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits", Arthritis Rheum, 46, pp.845~847 (2002)
126. Blackburn-Munro G, "Chronic pain, chronic stress and depression: coincidence or consequence?", J Neuroendocrinol, 13, pp.1009~1023 (2001)
127. Gold PW, "Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications", Endocrinol Metab Clin North Am, 31, pp.37~62 (2002)
128. Albrecht DS, "Brain glial activation in fibromyalgia : a multi-site positron emission tomography investigation", Brain Behav Immun, 75, pp.72~83 (2019)
129. Mendieta D, "IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients", J Neuroimmunol, 290, pp.22~25 (2016)
130. Wallace DJ, "Cytokines play an aetiopathogenetic role in fibromyalgia : a hypothesis and pilot study", Rheumatology(Oxford), 40, pp.743~749 (2001)
131. Dowlati Y, "A meta-analysis of cytokines in major depression", Biol Psychiatry, 67, pp.446~457 (2010)
132. Goebel A, "Passive transfer of fibromyalgia symptoms from patients to mice", J Clin Invest, 131, pp.e144201~ (2021)
133. Klein R, "High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders", Eur J Med Res, 1, pp.21~26 (1995)
134. Werle E, "Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome", J Rheumatol, 28, pp.595~600 (2001)
135. Bazzichi L, "Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia?", Rheumatol Int, 32, pp.335~341 (2012)
136. Pamuk ON, "The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms", Clin Rheumatol, 26, pp.55~59 (2007)
137. Bote ME, "Inflammatory", stress feedback dysregulation in women with fibromyalgia, 2012, pp.19, 343~351
138. Imamura M, "Concentration of cytokines in patients with osteoarthritis of the knee and fibromyalgia", Clin Interv Aging, 9, pp.939~944 (2014)
139. Ranzolin A, "Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia: a controlled cross-sectional study", Cytokine, 84, pp.25~28 (2016)
140. Rodriguez-Pintó I, "Fibromyalgia and cytokines", Immunol Lett, 161, pp.200~203 (2014)
141. O’Mahony LF, "Is fibromyalgia associated with a unique cytokine profile? : a systematic review and meta-analysis", Rheumatology(Oxford), 60, pp.2602~2614 (2021)
142. Crosson T, "Profiling of how nociceptor neurons detect danger : new and old foes", J Intern Med, 286, pp.268~289 (2019)
143. Basbaum AI, "Cellular and molecular mechanisms of pain", Cell, 139, pp.267~284 (2009)
144. Chavan SS, "Mechanisms and therapeutic relevance of neuro-immune communication", Immunity, 46, pp.927~942 (2017)
145. Scholz J, "The neuropathic pain triad: neurons, immune cells and glia", Nat Neurosci, 10, pp.1361~1368 (2007)
146. Kadetoff D, "Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels", J Neuroimmunol, 242, pp.33~38 (2012)
147. Puma C, "The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs", J Neurochem, 78, pp.960~971 (2001)
148. Krock E, "Interleukin-8 as a therapeutic target for chronic low back pain : upregulation in human cerebrospinal fluid and pre-clinical validation with chronic reparixin in the SPARC-null mouse model", EBioMedicine, 43, pp.487~500 (2019)
149. Chiu IM, "Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology", Nat Neurosci, 15, pp.1063~1067 (2012)
150. Wallace DJ, "Is there a role for cytokine based therapies in fibromyalgia", Curr Pharm Des, 12, pp.17~22 (2006)
151. Pillemer SR, "The neuroscience and endocrinology of fibromyalgia", Arthritis Rheum, 40, pp.1928~1939 (1997)
152. "Wikipedia the free encyclopedia: Neuropeptide" (2023)[URL]
153. Vaerøy H, "Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis", Pain, 32, pp.21~26 (1988)
154. Russell IJ, "Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome", Arthritis Rheum, 37, pp.1593~1601 (1994)
155. Rossi SG, "Localization of the calcitonin gene-related peptide receptor complex at the vertebrate neuromuscular junction and its role in regulating acetylcholinesterase expression", J Biol Chem, 278, pp.24994~25000 (2003)
156. Maggi CA, "Tachykinins and calcitonin gene-related peptide(CGRP)as co-transmitters released from peripheral endings of sensory nerves", Prog Neurobiol, 45, pp.1~98 (1995)
157. Iyengar S, "The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine", Pain, 158, pp.543~559 (2017)
158. Korucu RU, "Serum calcitonin gene-related peptide and receptor protein levels in patients with fibromyalgia syndrome: a cross-sectional study", Arch Rheumatol, 35, pp.463~467 (2020)
159. Zhou Y, "Glutamate as a neurotransmitter in the healthy brain", J Neural Transm(Vienna), 121, pp.799~817 (2014)
160. Harris RE, "Elevated insular glutamate in fibromyalgia is associated with experimental pain", Arthritis Rheum, 60, pp.3146~3152 (2009)
161. Valdés M, "Increased glutamate", glutamine compounds in the brains of patients with fibromyalgia : a magnetic resonance spectroscopy study, 2010, pp.62, 1829~1836
162. Harris RE, "Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia", Arthritis Rheum, 58, pp.903~907 (2008)
163. Giovengo SL, "Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia", J Rheumatol, 26, pp.1564~1569 (1999)
164. Baumeister D, "No evidence for altered plasma NGF and BDNF levels in fibromyalgia patients", Sci Rep, 9, pp.13667~ (2019)
165. Juhl JH, "Fibromyalgia and the serotonin pathway", Altern Med Rev, 3, pp.367~375 (1998)
166. Potvin S, "Human evidence of a supra-spinal modulating role of dopamine on pain perception", Synapse, 63, pp.390~402 (2009)
167. Baraniuk JN, "Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain", BMC Musculoskelet Disord, 5, pp.48~ (2004)
168. Harris RE, "Decreased central mu-opioid receptor availability in fibromyalgia", J Neurosci, 27, pp.10000~10006 (2007)
169. Russell IJ, "Cerebrospinal fluid biogenic amine metabolites in fibromyalgia", fibrositis syndrome and rheumatoid arthritis, 1992, pp.35, 550~556
170. Sarchielli P, "Sensitization, glutamate, and the link between migraine and fibromyalgia", Curr Pain Headache Rep, 11, pp.343~351 (2007)
171. Staud R, "Peripheral pain mechanisms in chronic widespread pain", Best Pract Res Clin Rheumatol, 25, pp.155~164 (2011)
172. Borg-Stein J, "Management of peripheral pain generators in fibromyalgia", Rheum Dis Clin North Am, 28, pp.305~317 (2002)
173. Clauw DJ, "Fibromyalgia and related conditions", Mayo Clin Proc, 90, pp.680~692 (2015)
174. Gerwin R, "Are peripheral pain generators important in fibromyalgia and chronic widespread pain?", Pain Med, 14, pp.777~778 (2013)
175. Üçeyler N, "Small fibre pathology in patients with fibromyalgia syndrome", Brain, 136(Pt 6), pp.1857~1867 (2013)
176. Oaklander AL, "Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia", Pain, 154, pp.2310~2316 (2013)
177. Grayston R, "A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia : implications for a new paradigm in fibromyalgia etiopathogenesis", Semin Arthritis Rheum, 48, pp.933~940 (2019)
178. Gerdle B, "Decreased muscle concentrations of ATP and PCR in the quadriceps muscle of fibromyalgia patients : a 31P-MRS study", Eur J Pain, 17, pp.1205~1215 (2013)
179. Drewes AM, "Pathology of skeletal muscle in fibromyalgia: a histo-immuno-chemical and ultrastructural study", Br J Rheumatol, 32, pp.479~483 (1993)
180. Blanco I, "Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients", Clin Rheumatol, 29, pp.1403~1412 (2010)
181. Bunimovich O, "Systemic mastocytosis: classification, pathogenesis, diagnosis, and treatment", Cutis, 83, pp.29~36 (2009)
182. Staud R, "Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study", Pain, 145, pp.96~104 (2009)
183. Bengtsson M, "Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise", Pain, 39, pp.171~180 (1989)
184. Staud R, "Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia", CNS Spectr, 13(3 Suppl 5), pp.12~17 (2008)
185. Nijs J, "Central sensitisation in chronic pain conditions : latest discoveries and their potential for precision medicine", Lancet Rheumatol, 3, pp.e383~e392 (2021)
186. Woolf CJ, "Central sensitization: implications for the diagnosis and treatment of pain", Pain, 152(3 Suppl), pp.S2~S15 (2011)
187. Desmeules JA, "Neurophysiologic evidence for a central sensitization in patients with fibromyalgia", Arthritis Rheum, 48, pp.1420~1429 (2003)
188. McDermid AJ, "Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification", Pain, 66, pp.133~144 (1996)
189. Geisser ME, "A psychophysical study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls", J Pain, 9, pp.417~422 (2008)
190. Martenson ME, "A possible neural mechanism for photosensitivity in chronic pain", Pain, 157, pp.868~878 (2016)
191. Larson AA, "Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways", Pain, 87, pp.201~211 (2000)
192. Uta D, "Neuronal sensitization and synaptic facilitation in the superficial dorsal horn of a rat reserpine-induced pain model", Neuroscience, 479, pp.125~139 (2021)
193. Gracely RH, "Pain catastrophizing and neural responses to pain among persons with fibromyalgia", Brain, 127(Pt 4), pp.835~843 (2004)
194. Napadow V, "What has functional connectivity and chemical neuroimaging in fibromyalgia taught us about the mechanisms and management of ‘centralized’ pain?", Arthritis Res Ther, 16, pp.425~ (2014)
195. Loggia ML, "Disrupted brain circuitry for pain-related reward", punishment in fibromyalgia, 2014, pp.66, 203~212
196. Napadow V, "Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia", Arthritis Rheum, 64, pp.2398~2403 (2012)
197. Kuchinad A, "Accelerated brain gray matter loss in fibromyalgia patients : premature aging of the brain?", J Neurosci, 27, pp.4004~4007 (2007)
198. Burgmer M, "Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia", Psychosom Med, 71, pp.566~573 (2009)
199. Kim DJ, "Altered white matter integrity in the corpus callosum in fibromyalgia patients identified by tract-based spatial statistical analysis", Arthritis Rheumatol, 66, pp.3190~3199 (2014)
200. Yunus MB, "Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study", J Rheumatol, 19, pp.90~94 (1992)
201. Jensen KB, "Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain", Pain, 144, pp.95~100 (2009)
202. Truini A, "Abnormal resting state functional connectivity of the periaqueductal grey in patients with fibromyalgia", Clin Exp Rheumatol, 34(2 Suppl 96), pp.S129~S133 (2016)
203. Jensen KB, "Patients with fibromyalgia display less functional connectivity in the brain’s pain inhibitory network", Mol Pain, 8, pp.32~ (2012)
204. Ioachim G, "Altered pain in the brainstem and spinal cord of fibromyalgia patients during the anticipation and experience of experimental pain", Front Neurol, 13, pp.862976~ (2022)
205. Foerster BR, "Reduced insular γ-aminobutyric acid in fibromyalgia", Arthritis Rheum, 64, pp.579~583 (2012)
206. Staud R, "Spinal cord neural activity of patients with fibromyalgia and healthy controls during temporal summation of pain : an fMRI study", J Neurophysiol, 126, pp.946~956 (2021)

관련 논문AI추천